Amino Acid Dysregulation Metabotypes Diagnostic for Autism Spectrum Disorder – AAN 2018 [PDF]
Presented at the American Association of Neurology in Los Angeles, California; April 2018
NeuroPointDX’s autism clinical study, Children’s Autism Metabolome Project (CAMP), is the largest study to identify changes in metabolism associated with autism spectrum disorder (ASD). Over 1,100 children enrolled in the study at eight clinical sites across the United States. NeuroPointDX developed a test panel for metabolic subtypes (metabotypes) associated with ASD.
Posters & Publications
- RT @ASDMentalHealth: Research Summaries of Studies on Managing Anxiety in the Classroom - Autism Mental Health Blog https://t.co/oByYtNSCQM…6 hours ago
- For a quick overview of the #NPDX #ASD test, read our brochure. Print it out and bring it to your next appointment… https://t.co/kMfhnHBBs46 hours ago
- RT @TACAfoundation: You've got this! #AutismTough Keep on keeping ON https://t.co/XDmxg4OVyS https://t.co/lSpCRnaEl25 days ago